Shanghai Henlius Biotech, Inc. Class H Financial Overview
Shanghai Henlius Biotech, Inc. Class H's market cap is currently HK$38.94B. The company's EPS TTM is HK$; its P/E ratio is 43.75; Shanghai Henlius Biotech, Inc. Class H is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Shanghai Henlius Biotech, Inc. Class H Earnings and Revenue History
